Stocks Hitting 52-Week Lows
February 17, 2015 at 10:15 AM EST
Celsus Therapeutics Plc (NASDAQ: CLTX) shares touched a new 52-week low of $1.18 on failed Phase 2 MRX-6 cream trial. Onconova ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.